The estimated Net Worth of Lee Nisley Newcomer is at least $1.91 Миллион dollars as of 13 May 2024. Lee Newcomer owns over 6,200 units of Myriad Genetics stock worth over $1,751,562 and over the last 5 years he sold MYGN stock worth over $156,860. In addition, he makes $0 as Independent Director at Myriad Genetics.
Lee has made over 1 trades of the Myriad Genetics stock since 2024, according to the Form 4 filled with the SEC. Most recently he sold 6,200 units of MYGN stock worth $156,860 on 13 May 2024.
The largest trade he's ever made was selling 6,200 units of Myriad Genetics stock on 13 May 2024 worth over $156,860. On average, Lee trades about 620 units every 0 days since 2019. As of 13 May 2024 he still owns at least 66,650 units of Myriad Genetics stock.
You can see the complete history of Lee Newcomer stock trades at the bottom of the page.
Dr. Lee Nisley Newcomer M.D., is an Independent Director of the Company. Dr. Newcomer currently manages his own consulting business, Lee N. Newcomer Consulting, LLC, and previously held senior executive roles at United Healthcare including Senior Vice President for Oncology and Genetics, Chief Medical Officer and Senior Vice President of Health Policy and Strategy for UnitedHealth Group. Dr. Newcomer also worked for Vivius, Inc., a consumer directed health plan, holding the position of Executive Vice President and Chief Medical Officer. Dr. Newcomer received a Master’s Degree in Healthcare Administration & Management from the University of Wisconsin, Madison, an M.D. from the University of Nebraska, Omaha, and a B.S. from Nebraska Wesleyan University. Dr. Newcomer currently serves on the Board of Cellworks Group Inc., a private precision medicine company and Intervention Insights, a genomic test deision support company. He also served on the board of directors of Park Nicollet Health Systems, a hospital health care system with approximately 1,000 physicians and 400 beds, for 10 years including two years as Chairman.
Lee Newcomer is 66, he's been the Independent Director of Myriad Genetics since 2019. There are 4 older and 22 younger executives at Myriad Genetics. The oldest executive at Myriad Genetics, Inc. is Walter Gilbert, 87, who is the Independent Vice Chairman of the Board.
Lee's mailing address filed with the SEC is 320, Wakara Way, U of U Research Park, Salt Lake City, Salt Lake County, Utah, 84108, United States.
Over the last 22 years, insiders at Myriad Genetics have traded over $51,783,466 worth of Myriad Genetics stock and bought 61,160 units worth $1,252,955 . The most active insiders traders include Jerry S Lanchbury, Peter D Meldrum и Arthur H Jr Hayes. On average, Myriad Genetics executives and independent directors trade stock every 18 days with the average trade being worth of $563,312. The most recent stock trade was executed by Heinrich Dreismann on 9 September 2024, trading 10,000 units of MYGN stock currently worth $270,500.
myriad genetics inc., is a leading personalized medicine company dedicated to being a trusted advisor transforming patient lives worldwide with pioneering molecular diagnostics. myriad discovers and commercializes molecular diagnostic tests that: determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major medical specialties where molecular diagnostics can significantly improve patient care and lower healthcare costs. myriad is focused on three strategic imperatives: maintaining leadership in an expanding hereditary cancer market, diversifying its product portfolio through the introduction of new products and increasing the revenue contribution from international markets. for more information on how myriad is making a difference, please visit the company's website: www.myriad.com.
Myriad Genetics executives and other stock owners filed with the SEC include: